Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee arthroplasty.
Risk-adjusted in-hospital mortality is significantly increased at safety-net hospitals for patients undergoing percutaneous coronary intervention.
The incidence of all strokes decreased over time in men, but not women, due to a decrease in ischemic stroke.
Researchers found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking.
The gene-editing tool called CRISPR-Cas9 could have the potential to treat and prevent other genetic diseases.
The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease.
Stopping statin therapy 3 to 6 months after an initial ischemic stroke may increase risk of a recurrent stroke.
A 30-year-old woman presents with an increased heart rate, shortness of breath, and tingling in her right arm.
Data from a clinical trial show that patients taking daily aspirin were not at heightened risk of being hospitalized for heart failure.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
Researchers sought to examine the link between intelligence scores during childhood and leading causes of death during the life course.
The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea.
Researchers found that idarucizumab is effective for dabigatran reversal among patients with uncontrolled bleeding and who are undergoing urgent surgery.
Users of opioid-only agents had significantly increased rates of emergency room visits and hospitalizations for ischemic heart disease and IHD-related mortality.
Primary care providers can help significantly reduce heart failure exacerbations and improve their patients' overall quality of life.
There were 526.86 hospital admissions for every 100,000 people in 2002, compared with 364.66 per 100,000 in 2013.
Clinicians will encounter more patients at risk for CHF as the population ages and cardiovascular risk factors become more prevalent.
The researchers found that during 13,509 patient-years of follow-up, 3166 patients had 405 first bleeding events.
Researchers found that 16% of patients received doses inconsistent with US Food and Drug Administration labeling.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Blood pressure levels below the recommended targets lower risk of CVD and all-cause mortality.
Compared with individuals reporting chocolate intake less than once per month, the rate of AF was lower for people consuming chocolate regularly.
The ALLHAT-LLT trial showed that statin therapy for primary cardiovascular prevention may not benefit adults older than 65 years of age.
CVD occurred in 11.8% of participants in the vitamin D group and 11.5% in the placebo group.
The USPSTF recommends that pregnant women receive screening for preeclampsia with blood pressure measurements throughout pregnancy.
Apixaban is associated with a lower risk of gastrointestinal bleeding than rivaroxaban or dabigatran.
Nine million fewer adults would be taking statins if clinicians followed the USPSTF guidelines.
Most patients in primary care with undiagnosed chest pain do not undergo diagnostic testing.
The researchers found heterogeneity in the association between recorded alcohol consumption and the initial presentation of 12 cardiovascular diseases.
A 44-year-old man presents to his local urgent care clinic for chest pain radiating up into his neck that is gradually getting worse.